Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
If your insurance denies coverage for a GLP-1, you may still be able to use a savings card, provided you meet the manufacturers eligibility requirements
Clinical trials show higher rates of gallstones and cholecystitis in patients taking GLP-1 drugs compared to placebo, though the absolute risk remains relatively low
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Discuss any changes with your healthcare provider
US$ 22.63
US$ 29.18
US$ 21.81
US$ 4730.10
Sold : Login>>
